Conatus Pharmaceuticals Inc.
16745 W. Bernardo Dr., Suite 200
San Diego, CA 92127
November 8, 2017
Division of Corporation Finance
Office of Healthcare & Insurance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
|Re:||Conatus Pharmaceuticals Inc.|
Registration Statement on Form S-3
Filed August 17, 2017
File No. 333-220014
Dear Ms. Westbrook:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Conatus Pharmaceuticals Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 10, 2017, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Cheston J. Larson, Esq. of Latham & Watkins LLP at (858) 523-5435. Thank you for your assistance and cooperation in this matter.
|Very truly yours,|
|CONATUS PHARMACEUTICALS INC.|
|By:||/s/ Steven J. Mento, Ph.D.|
|Steven J. Mento, Ph.D.|
|President and Chief Executive Officer|
|cc:||Cheston J. Larson, Esq., Latham & Watkins LLP|
Matthew T. Bush, Esq., Latham & Watkins LLP
Christopher G. Geissinger, Esq., Latham & Watkins LLP